# Therapeutic Advances in Gastroenterology 9(4)

bowel disease: an assessment of carriage in an outpatient setting among patients in remission. Am J Gastroenterol 104: 1162–1169.

Cohen, S., Gold, B., Oliva, S., Lewis, J., Stallworth, A., Koch, B. et al. (2014) Clinical and mucosal improvement with specific carbohydrate diet in pediatric Crohn disease. J Pediatr Gastroenterol Nutr 59: 516–521.

Collins, S., Surette, M. and Bercik, P. (2012) The interplay between the intestinal microbiota and the brain. Nat Rev Microbiol 10: 735–742.

Colman, R. and Rubin, D. (2014) Fecal microbiota transplantation as therapy for inflammatory bowel disease: a systematic review and meta-analysis. J Crohns Colitis 8: 1569–1581.

Cosnes, J. (2008) What is the link between the use of tobacco and IBD? Inflamm Bowel Dis 14(Suppl. 2): S14–S15.

Cosnes, J., Carbonnel, F., Carrat, F., Beaugerie, L. and Gendre, J. (1999) Oral contraceptive use and the clinical course of Crohn’s disease: a prospective cohort study. Gut 45: 218–222.

Critch, J., Day, A., Otley, A., King-Moore, C., Teitelbaum, J., Shashidhar, H. et al. (2012) Use of enteral nutrition for the control of intestinal inflammation in pediatric Crohn disease. J Pediatr Gastroenterol Nutr 54: 298–305.

Cui, B., Feng, Q., Wang, H., Wang, M., Peng, Z., Li, P. et al. (2015) Fecal microbiota transplantation through mid-gut for refractory crohn’s disease: safety, feasibility, and efficacy trial results. J Gastroenterol Hepatol 30: 51–58.

Dalal, S. and Chang, E. (2014) The microbial basis of inflammatory bowel diseases. J Clin Invest 124: 4190–4196.

Damman, C. (2013) Salicylates and the microbiota: a new mechanistic understanding of an ancient drug’s role in dermatological and gastrointestinal disease. Drug Development Research 74: 344–352.

Damman, C., Brittnacher, M., Westerhoff, M., Hayden, H., Radey, M., Hager, K. et al. (2015) Low level engraftment and improvement following a single colonoscopic administration of fecal microbiota to patients with ulcerative colitis. PLoS One 10: e0133925.

Damman, C., Miller, S., Surawicz, C. and Zisman, T. (2012) The microbiome and inflammatory bowel disease: is there a therapeutic role for fecal microbiota transplantation? Am J Gastroenterol 107: 1452–1459.

Darfeuille-Michaud, A., Boudeau, J., Bulois, P., Neut, C., Glasser, A., Barnich, N. et al. (2004) High prevalence of adherent-invasive Escherichia coli associated with ileal mucosa in Crohn’s disease. Gastroenterology 127: 412–421.

David, L., Maurice, C., Carmody, R., Gootenberg, D., Button, J., Wolfe, B. et al. (2014) Diet rapidly and reproducibly alters the human gut microbiome. Nature 505: 559–563.

D’Inca, R., Annese, V., Di Leo, V., Latiano, A., Quaino, V., Abazia, C. et al. (2006) Increased intestinal permeability and NOD2 variants in familial and sporadic Crohn’s disease. Aliment Pharmacol Ther 23: 1455–1461.

Deplancke, B. and Gaskins, H. (2001) Microbial modulation of innate defense: goblet cells and the intestinal mucus layer. Am J Clin Nutr 73: 1131S-1141S.

Derrien, M., Vaughan, E., Plugge, C. and De Vos, W. (2004) Akkermansia muciniphila gen. nov., sp. nov., a human intestinal mucin-degrading bacterium. Int J Syst Evol Microbiol 54: 1469–1476.

Devkota, S., Wang, Y., Musch, M., Leone, V., Fehlner-Peach, H., Nadimpalli, A. et al. (2012) Dietary-fat-induced taurocholic acid promotes pathobiont expansion and colitis in IL10-/- mice. Nature 487: 104–108.

Di Bella, S., Gouliouris, T. and Petrosillo, N. (2015) Fecal microbiota transplantation (FMT) for Clostridium difficile infection: focus on immunocompromised patients. J Infect Chemother 21: 230–237.

Dominguez-Bello, M., Costello, E., Contreras, M., Magris, M., Hidalgo, G., Fierer, N. et al. (2010) Delivery mode shapes the acquisition and structure of the initial microbiota across multiple body habitats in newborns. Proc Natl Acad Sci U S A 107: 11971–11975.

Dupont, H. (2014) Review article: evidence for the role of gut microbiota in irritable bowel syndrome and its potential influence on therapeutic targets. Aliment Pharmacol Ther 39: 1033–1042.

Eckburg, P., Bik, E., Bernstein, C., Purdom, E., Dethlefsen, L., Sargent, M. et al. (2005) Diversity of the human intestinal microbial flora. Science 308: 1635–1638.

Edelblum, K. and Turner, J. (2009) The tight junction in inflammatory disease: communication breakdown. Curr Opin Pharmacol 9: 715–720.

Faith, J., Rey, F., O’Donnell, D., Karlsson, M., McNulty, N., Kallstrom, G. et al. (2010) Creating and characterizing communities of human gut microbes in gnotobiotic mice. ISME J 4: 1094–1098.

Fallani, M., Young, D., Scott, J., Norin, E., Amarri, S., Adam, R. et al. (2010) Intestinal microbiota of 6-week-old infants across Europe: geographic

618 http://tag.sagepub.com